Cargando…
Clinical outcomes and hemodynamic performance of Dafodil™ aortic and mitral pericardial bioprosthesis: 1-year results from Dafodil-1 first-in-human trial
BACKGROUND: Bioprosthesis has been increasingly implanted for the treatment of transvalvular disease across the world. A new Dafodil™ pericardial bioprosthesis (Meril Life Sciences Pvt. Ltd., India) recently approved by Conformité Européenne (CE) is a tri-leaflet, stented, bovine valve. The purpose...
Autores principales: | Hiremath, C. S., Jain, Anil R., Garg, Anurag, Gupta, Nirmal, Mishra, Yugal K., Meharwal, Zile Singh, Thakur, Nityanand, Maslekar, Atul A., Shastri, Naman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7294644/ https://www.ncbi.nlm.nih.gov/pubmed/32539847 http://dx.doi.org/10.1186/s13019-020-01154-7 |
Ejemplares similares
-
Bioprosthesis in the Mitral Position: Bovine Pericardial versus Porcine Xenograft
por: Han, Dong Youb, et al.
Publicado: (2022) -
Structural valve deterioration of a pericardial bioprosthesis
por: Kattach, Hassan, et al.
Publicado: (2021) -
Structural valve deterioration of a mitral Carpentier-Edwards pericardial bioprosthesis in an 87-year-old woman 16 years after its implantation
por: Ito, Hiroshi, et al.
Publicado: (2011) -
“Equal to the challenge” Cardiac surgery in India – as many opportunities as there are challenges
por: Meharwal, Zile Singh
Publicado: (2023) -
Transcatheter transapical valve-in-valve implantation for degenerated mitral bioprosthesis
por: Lelek, Michał, et al.
Publicado: (2017)